Hudson Bay Capital Management LP Mereo Biopharma Group PLC Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 315,000 shares of MREO stock, worth $724,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315,000
Previous 175,000
80.0%
Holding current value
$724,500
Previous $719,000
53.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MREO
# of Institutions
99Shares Held
116MCall Options Held
151KPut Options Held
455K-
Janus Henderson Group PLC London, X017.1MShares$39.4 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$35.2 Million0.89% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.6MShares$22.1 Million1.34% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.72MShares$20 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.64MShares$19.9 Million4.71% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $287M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...